Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.

Media spotlight: PSI experts on Bundibugyo Ebola vaccines and treatments

Several UK and global outlets have covered Oxford’s response to the Bundibugyo Ebola virus outbreak currently affecting the DRC and Uganda.

UK launches a study of Andes hantavirus using a pre-approved outbreak protocol

Study uses ISARIC's globally recognised Clinical Characterisation Protocol

Media Spotlight: PSI experts comment on hantavirus outbreak

PSI members have provided expert comment on the recent hantavirus outbreak across a range of media.

Three new Associate Professorships confirm PSI’s continued impact in research, teaching and service

Announcement recognises colleagues’ significant and sustained contribution to the University of Oxford.

International Pandemic Sciences Conference 2026: strengthening preparedness and building resilience

From 1 to 3 July 2026, the International Pandemic Sciences Conference will bring together leading scientists, policymakers, and practitioners in Singapore and online to explore how we can strengthen pandemic preparedness, resilience and equitable access to science.

Two PSI members among the first Fellows of the Academy for the Mathematical Sciences

The Academy for the Mathematical Sciences will bring together the UK’s strongest mathematicians across academia, education, business, industry, and government to help solve some of the UK’s biggest challenges.

New review provides insights to inform future Nipah virus clinical trials

The review, which has been published in The Lancet Microbe, addresses critical knowledge gaps, helping to inform the design of future clinical trials and improve patient treatment.

PSI supports the 100 Days Mission Implementation Report’s call to reinvigorate pandemic preparedness research and development

Several PSI activities and initiatives have been identified as contributing to the 100 Days Mission's goal to prepare as much as possible within the first 100 days of a pandemic.

Join us for the International Pandemic Sciences Conference 2026

Co-hosted by PSI and Singapore’s Programme for Research in Epidemic Preparedness and REsponse (PREPARE), this year's conference will take place in Singapore and online from 1 to 3 July 2026.

New toolkit offers practical guidance to tackle stigma in infectious disease outbreaks

Thirty international experts collaborated to produce the ISARIC Anti-Stigma Guidelines: a practical toolkit designed for use in outbreak response planning and delivery.

First volunteer receives Lassa fever vaccine in cutting-edge Oxford trial

The vaccine developed by PSI researchers aims to advance the fight against Lassa fever virus, a WHO priority pathogen posing a significant public health risk.

PSI-Dr Jenner’s House collaborative school’s programme wins educational award

The Frances Garnham Award for Education celebrates innovative approaches to educational or community engagement.

PSI Director calls for stronger pandemic intelligence after UK Covid-19 Inquiry Module 2 report published

Professor Sir Peter Horby comments on the UK Covid-19 Inquiry Module 2 report.

UK must step up its pandemic preparedness plans

PSI colleagues Professor Alice Norton, Professor Samantha Vanderslott and Professor Sir Peter Horby reflect on what the WHO Pandemic Agreement means for the UK, in a BMJ editorial.

Bubonic plague treatment proven highly effective and safe in global first

Researchers from the UK and Madagascar, in collaboration with Madagascar’s health services and national plague programme, have conducted the world’s first rigorous clinical trial of treatments for bubonic plague.

New WHO Collaborating Centre for Genomic Surveillance of Antimicrobial Resistance launched

Hosted by the Centre for Genomic Pathogen Surveillance at PSI, the new Centre will support efforts to tackle one of the most pressing global health challenges of our time.

Construction begins on state-of-the-art research facility

The University of Oxford held a groundbreaking ceremony on Tuesday 24 June to celebrate the start of construction of the Cyrus Poonawalla Vaccines Research Building. The ceremony marks a significant milestone in Oxford’s mission to counter and constrain global health threats.

First validated tool to measure stigma during multiple infectious disease outbreaks published

The new RAPID Stigma Scales, led by researchers at the PSI, will help health professionals to monitor stigma in disease outbreak settings, improving outbreak responses globally.

Two new Associate Professorships demonstrate PSI’s impact in research, teaching and practice

The title recognises the researchers’ “significant and sustained academic contribution” to the University.

Load More